Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Hum Reprod ; 10(1): 7-14, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14665701

ABSTRACT

Arrested follicular maturation is a characteristic feature of polycystic ovary syndrome (PCOS). Follicles mature in ovarian stroma composed of extracellular matrix (ECM). However, little is known of the expression of ECM genes in polycystic ovaries. The present study compares the expression levels of genes coding for collagens, matrix metalloproteinases (MMP), their inhibitors (TIMP) and cathepsins in polycystic ovaries using fertile and post-menopausal ovaries as controls. In northern analyses, the gene expression profiles of type I and III collagen of PCOS samples resembled those observed in normal follicular phase ovaries, while mRNA levels of proalpha1(IV) collagen and TIMP-3 mRNA were significantly lower in polycystic than control ovaries. During the normal menstrual cycle, an increase was observed in MMP-9 gene expression during the luteal phase. In post-menopausal ovaries, mRNA levels for type I, III and IV collagens and osteonectin were reduced, while the MMP, TIMP (excluding TIMP-3) and cathepsins did not reflect this metabolic down-regulation. Immunohistochemical staining for MMP-9 and TIMP-4 suggested differences between polycystic and normally functioning ovaries. These data demonstrate that normal ovarian functions are associated with changes in production and degradation of ECM. The alterations observed in the production and/or distribution of type IV collagen, TIMP-3 and TIMP-4 suggest involvement of basement membranes in the pathogenesis of PCOS.


Subject(s)
Ovary , Tissue Inhibitor of Metalloproteinase-1 , Connective Tissue , Humans , Matrix Metalloproteinase 9/metabolism , Ovary/metabolism , Polycystic Ovary Syndrome/genetics , RNA, Messenger/metabolism , Tissue Inhibitor of Metalloproteinase-3/genetics
2.
Mol Hum Reprod ; 7(1): 27-34, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11134357

ABSTRACT

Cathepsins B, H, K, L and S belong to a family of lysosomal cysteine proteinases which participate in a variety of proteolytic processes, including degradation of extracellular matrix. Although the presence of cathepsin mRNAs in the ovary has been reported earlier, very little information is available on their temporospatial expression. In the present study, Northern analysis revealed cyclic changes in the mRNA levels for cathepsins B, H, K, L and S during the 4-day oestrous cycle in the mouse ovary. Immunohistochemical localization revealed distinct expression patterns suggesting different functions for the cathepsins studied. Cathepsin B was predominantly seen in the germinal epithelium throughout the oestrous cycle. Upon follicular maturation, an increasing number of granulosa cells became positive for all cathepsins. Strong cathepsin H staining was sharply defined in theca externa which also stained for cathepsins K and S. Corpus luteum was the predominant location of cathepsin L. The distribution of cathepsin S resembled that of cathepsin L. The developing oocyte stained positive for all cathepsins. In-situ hybridization confirmed the differential production of cathepsin mRNAs by granulosa, thecal and luteal cells. These complex temporal and spatial expression patterns at different stages of the oestrous cycle and follicular development suggest divergent functions for specific cathepsins in follicular development, growth and rupture.


Subject(s)
Cathepsins/genetics , Endopeptidases , Gene Expression Profiling , Ovary/metabolism , Animals , Blotting, Northern , Cathepsin B/genetics , Cathepsin H , Cathepsin K , Cathepsin L , Cysteine Endopeptidases/genetics , Female , Immunoenzyme Techniques , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , RNA, Messenger
3.
Mol Hum Reprod ; 7(1): 73-8, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11134363

ABSTRACT

Cathepsins B, H, K, L and S belong to the family of lysosomal cysteine proteinases and participate in a variety of proteolytic processes, including degradation of the extracellular matrix (ECM). In the present study, we used Northern hybridization to demonstrate the presence of mRNAs for cathepsins B, H, K, L and S in human endometrium during both the proliferative and secretory phases of menstrual cycle. The mRNA levels for cathepsins H and K were significantly lower in secretory phase endometrium in comparison with proliferative phase endometrium. Immunohistochemical localization of the different cathepsins revealed widespread distribution of all cathepsins in both stroma and epithelial cells. The immunoreactivity for cathepsins B, H and K exhibited changes related to endometrial location and/or to the phase of the cycle. The strongest immunoreactivity for cathepsins B, H, L and S was observed in the surface epithelium of the endometrium. The staining for cathepsins was predominantly intracellular, but immunoreactivity was also detected on the surface of small lymphoid cells in the stroma. The findings of the present study suggest that cysteine cathepsins are needed for normal development and function of human endometrium during both the proliferative and secretory phases.


Subject(s)
Cathepsins/genetics , Endometrium/metabolism , Endopeptidases , Adult , Blotting, Northern , Cathepsin B/biosynthesis , Cathepsin B/genetics , Cathepsin H , Cathepsin K , Cathepsin L , Cathepsins/biosynthesis , Cysteine Endopeptidases/biosynthesis , Cysteine Endopeptidases/genetics , Endometrium/pathology , Female , Gene Expression Profiling , Humans , Immunoenzyme Techniques
4.
Int J Cancer ; 88(5): 718-25, 2000 Dec 01.
Article in English | MEDLINE | ID: mdl-11072239

ABSTRACT

FGF-8 is a mitogenic growth factor, which is widely expressed during embryonic development but only at a very low level in adult tissues. Alternative splicing of the human FGF-8 gene potentially allows coding for 4 protein isoforms (a, b, e, f), which differ in their transforming capacity. The FGF-8 isoforms preferentially activate the receptors FGFR1IIIc, FGFR2IIIc, FGFR3IIIc and FGFR4. FGF-8 is over-expressed in human breast and prostate cancers. Expression has also been found in RT-PCR studies of human ovarian and testicular cancers. The present study was undertaken to examine which FGF-8 isoforms are expressed in ovarian cancer and whether FGF-8 receptors are also expressed. Specimens from 5 normal human ovaries and 51 ovarian tumors (1 benign tumor, 8 borderline malignancies, 42 malignant tumors of different histopathological types) were studied by RT-PCR and immunohistochemistry. FGF-8 isoform b was expressed in all ovarian tumors and in all 7 ovarian-cancer cell lines studied. Isoform a was co-expressed in 9 malignant ovarian tumors. FGF-8 mRNA was not detected by RT-PCR of 3 normal ovary samples. Immunohistochemical staining localized FGF-8 protein to cancer cells. In general, the increased intensity of FGF-8 staining was associated with loss of differentiation within the tumors (Bowker's test, p = 0.37). FGF-8 staining of surface epithelium observed on 2 normal ovaries was very faint. RT-PCR showed that FGFR1IIIc, FGFR2IIIc and FGFR4 were the FGF-8 receptors expressed in normal ovaries and in ovarian tumors. FGF-8 receptor immunoreactivity was preferentially found in normal ovary surface epithelium and tumor cells but also in some stromal cells. Collectively, our results show that ovarian cancers of a wide variety of histological types expressing receptors for FGF-8 have acquired the capacity of expressing FGF-8. This suggests that FGF-8 has an important role in ovarian tumorigenesis.


Subject(s)
Fibroblast Growth Factors/biosynthesis , Ovarian Neoplasms/metabolism , Receptors, Fibroblast Growth Factor/biosynthesis , Adult , Aged , Aged, 80 and over , Blotting, Southern , Female , Fibroblast Growth Factor 8 , Fibroblast Growth Factors/analysis , Fibroblast Growth Factors/genetics , Fibroblast Growth Factors/metabolism , Humans , Immunohistochemistry , Middle Aged , Ovarian Neoplasms/pathology , Protein Isoforms/biosynthesis , Protein Isoforms/genetics , RNA, Messenger/biosynthesis , Receptors, Fibroblast Growth Factor/genetics , Receptors, Fibroblast Growth Factor/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured
5.
Mol Hum Reprod ; 5(9): 803-8, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10460217

ABSTRACT

In the ovary, differentiation of germinal cells into primordial follicles, functional ovulatory follicles and corpus luteum, all take place in a connective tissue matrix. We postulated that extracellular matrix (ECM) of the ovary participates actively in ovarian functions. To test this, the mRNA levels for several ECM components were determined in the mouse ovary at six distinct stages of the 4-day oestrous cycle. Northern analysis revealed statistically significant cyclic expression patterns for the mRNAs coding for type III, IV and VI collagens as well as for the small proteoglycan, biglycan, and for syndecan-1 and osteonectin. The cyclic changes observed in the mRNAs for these structural components exceeded those for matrix metalloproteinases (MMP)-2, -9 and -13, and for tissue inhibitors of matrix metalloproteinases (TIMP)-1, -2 and -3, where the changes were not statistically significant, despite their apparent role in ECM remodelling in the ovary. These observations support the hypothesis that cyclic changes in the production and degradation of ECM are part of normal ovarian function connected with follicular maturation, rupture and corpus luteum formation.


Subject(s)
Collagen/genetics , Matrix Metalloproteinase 2/genetics , Ovary/cytology , Ovary/physiology , Proteoglycans/genetics , RNA, Messenger/analysis , Animals , Biglycan , Blotting, Northern , Carrier Proteins/genetics , Connective Tissue/chemistry , Connective Tissue/physiology , Connective Tissue Cells/physiology , Decorin , Estrus/physiology , Extracellular Matrix Proteins/genetics , Female , Fibromodulin , Gene Expression Regulation , Matrix Metalloproteinase 9/genetics , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Osteonectin/genetics , Syndecan-1 , Syndecans , Tissue Inhibitor of Metalloproteinase-1/genetics , Tissue Inhibitor of Metalloproteinase-2/genetics , Tissue Inhibitor of Metalloproteinase-3/genetics , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...